Browse EX-10 agreements

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 1, 2026 (the “Effective Date”), is entered into by and between Yossef Ehrlichman (the “Executive”) and Q/C Technologies, Inc. (the “Company”). The Company and the Executive shall be referred to herein as the “Parties” and each as a “Party.”

** **

RECITALS

Whereas, the Company desires to employ the Executive as its Founding Manager of PIC Development, and the Executive desires to be employed by the Company as its Founding Manager of PIC Development effective as of the Effective Date; and

Whereas, the Company and the Executive desire to state in writing the terms and conditions of their agreement and understandings with respect to the employment of the Executive on and after the Effective Date.

…

fIRST AMENDMENT TO EMPLOYMENT AGREEMENT

This first AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), is entered into as of September __, 2026 (the “Effective Date”), by and between Yossef Ehrlichman (the “Executive”) and Q/C Technologies, Inc., a Delaware corporation (the “Company”), for the purpose of amending that certain Employment Agreement, dated as of August 1, 2026 by and between the Executive and the Company (the “Employment Agreement”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Employment Agreement.

WHEREAS, Article V.G of the Employment Agreement provides that the Employment Agreement may be amended, modified, or waived only with the prior written consent of the Company and the Executive; and

WHEREAS, the parties mutually desire to modify certain provisions that would otherwise apply to Executive’s title and base salary pursuant to the Employment Agreement.

…

Senior Secured Convertible Note

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY THIS SECURITY.

Original Issue Date: September 14, 2026	Funding Amount	$ 1,575,000
Final Maturity Date: March 1, 2027	Original Principal Amount:	$ 2,126,250

CDT EQUITY INC.

…

Execution Version

ROUNDTABLE STRATEGIC PLATFORM AGREEMENT

PARTNER		Paradium.AI, Inc. f/k/a The Arena Group Holdings, Inc.
EFFECTIVE DATE:		Upon Completion of Certain Conditions Precedent
ADDITIONAL TERMS:		All Exhibits

…

Execution Version

ROUNDTABLE STRATEGIC PLATFORM AGREEMENT

PARTNER		Paradium.AI, Inc. f/k/a The Arena Group Holdings, Inc.
EFFECTIVE DATE:		Upon Completion of Certain Conditions Precedent
ADDITIONAL TERMS:		All Exhibits

…

LENNOX INTERNATIONAL INC.

Long-Term Incentive Award Agreement

U.S. Employees – Vice President and Above

THIS AGREEMENT (“Agreement”) is made as of ______________ (the “Date of Grant”), by and between Lennox International Inc., a Delaware corporation (the “Company”), and __________ (“Participant”).

The Company has adopted the Lennox International Inc. 2019 Equity and Incentive Compensation Plan (as amended and restated from time to time, the “Plan”), the terms of which are incorporated by reference and made a part of this Agreement, for the benefit of eligible employees, Directors, and certain other service providers of the Company and its Subsidiaries (together, “LII”). Capitalized terms used and not otherwise defined in this Agreement have the meanings set forth in the Plan.

…

CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (1) NOT MATERIAL AND (2) OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

RESEARCH COLLABORATION AND LICENSE AGREEMENT

BY AND AMONG

ELI LILLY AND COMPANY,

TREX BIO, INC., AND

TREX HOLDINGS INC.

---

Table of Contents

Page

Article 1 Definitions	1
Article 2 OVERVIEW; Licenses; Exclusivity	15
2.1. Overview	15
2.2. License Grants	15

…

LEASE AGREEMENT

THIS LEASE AGREEMENT (this “Lease”) is made this 15thday of April, 2026 (the “Effective Date”), between ARE-SAN FRANCISCO NO. 46, LLC, a Delaware limited liability company (“Landlord”), and TREX BIO, INC., a Delaware corporation (“Tenant”).

BASIC LEASE PROVISIONS

| | |

…

FIRST AMENDMENT TO

RESEARCH COLLABORATION AND LICENSE AGREEMENT

This First Amendment to the Research Collaboration and License Agreement (this “FirstAmendment”), dated as of [XX], 2026 (“First AmendmentEffective Date”), is made by and between Eli Lilly and Company,an Indiana corporation (“Lilly”), and TRex Bio, Inc., a Delaware corporation (“TRex”). Lilly and TRex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

WHEREAS, Lilly, TRex, and TRex Holdings Inc., a Delaware corporation (“TRex Holdings”), are parties to that certain Research Collaboration and License Agreement dated January 6, 2023 (the “Original Agreement” and, as amended by this First Amendment, the “Agreement”) and capitalized terms used in this First Amendment shall have the meanings ascribed to them in the Original Agreement unless otherwise defined herein;

…

Stock Option Agreement

TRex Bio, Inc.

2024 Equity Incentive Plan

This Stock Option Agreement (this “Agreement”) is made and entered into as of the date of grant (the “Date of Grant”) set forth on the Notice of Stock Option Grant attached as the facing page to this Agreement (the “Grant Notice”) by and between TRex Bio. Inc., a Delaware corporation (the “Company”), and the optionee named on the Grant Notice (“Optionee”). Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Company’s 2024 Equity Incentive Plan (the “Plan”) or in the Grant Notice, as applicable.

1.

…

TREX BIO, INC.

2024 EQUITY INCENTIVE PLAN

As Adopted on December 31, 2024

1. PURPOSE. The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, its Parent and Subsidiaries by offering eligible persons an opportunity to participate in the Company’s future performance through the grant of Awards covering Shares. Capitalized terms not defined in the text are defined in Section 14 hereof. Although this Plan is intended to be a written compensatory benefit plan within the meaning of Rule 701, grants may be made pursuant to this Plan that do not qualify for exemption under Rule 701 or Section 25102(o). Any requirement of this Plan that is required in law only because of Section 25102(o) need not apply if the Committee so provides.

2. SHARES SUBJECT TO THE PLAN.

…

Stock Option Agreement

TRex Bio, Inc.

2024 Equity Incentive Plan

This Stock Option Agreement (this “Agreement”) is made and entered into as of the date of grant (the “Date of Grant”) set forth on the Notice of Stock Option Grant attached as the facing page to this Agreement (the “Grant Notice”) by and between TRex Bio, Inc., a Delaware corporation (the “Company”), and the optionee named on the Grant Notice (“Optionee”). Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Company’s 2024 Equity Incentive Plan (the “Plan”) or in the Grant Notice, as applicable.

1.

…